Utilization of plasmapheresis for organophosphate intoxication: A case report  by Disel, Nezihat Rana et al.
lable at ScienceDirect
Turkish Journal of Emergency Medicine 16 (2016) 69e71Contents lists avaiTurkish Journal of Emergency Medicine
journal homepage: http : / /www.elsevier .com/locate/TJEMCase reportUtilization of plasmapheresis for organophosphate intoxication: A
case report
Nezihat Rana Disel*, Ayca Acikalin, Zeynep Kekec, Ahmet Sebe
Cukurova University, Faculty of Medicine, Department of Emergency Medicine, Adana, Turkeya r t i c l e i n f o
Article history:
Received 18 March 2015
Received in revised form
9 June 2015
Accepted 21 June 2015






Ichthyosis* Corresponding author. Cukurova Universitesi, Ti
limdali, 01260 Adana, Turkey. Tel.: þ90 32233860
(mobile).
E-mail address: ranalpay@gmail.com (N.R. Disel).
Peer review under responsibility of The Emerge
Turkey.
http://dx.doi.org/10.1016/j.tjem.2015.06.003
2452-2473/Copyright © 2016 The Emergency Medicin
under the CC BY-NC-ND license (http://creativecomma b s t r a c t
Organophosphate (OP) compounds are extremely toxic chemicals that may be absorbed via skin, con-
junctiva, gastrointestinal and respiratory systems. Treatment of OP poisoning is a critical and aggressive
process which includes decontamination, antidote administration (atropin and oximes), mechanical
ventilation support and extracorporeal elimination procedures if needed. Here we present a young fe-
male patient who was unintentionally poisoned by an OP (trichlorfon) after using it to moisture her skin.
The importance of this patient is the dermal disease that makes her unprotective to dermal exposure of
chemicals and application of plasmapheresis to treat her poisoning.
Copyright © 2016 The Emergency Medicine Association of Turkey. Production and hosting by Elsevier
B.V. on behalf of the Owner. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Organophosphate (OP) compounds are frequently used in-
secticides in agriculture, animal care and pest control in living
areas. These chemicals are toxic because they inhibit the enzyme
acetylcholinesterase in erythrocyte membranes, skeletal muscle
and nerve tissue that result in cholinergic crisis. These insecticides
can be absorbed from mucous membranes, skin, conjunctiva,
gastrointestinal and respiratory tracts. Poisonings may result from
accidental exposures or intentionally in homicides and suicides.1
Here we present a-19-year old woman who admitted to emer-
gency department of our university hospital with the complaints of
nausea, vomiting and fatigue after using a solution containing
trichlorfon to moisture her skin with the advice of a veterinary.2. Case presentation
A 19-year-old female was referred from an urban hospital to the
emergency department (ED) of our university hospital after using ap Fakultesi, Acil Tip Anabi-
60x3281, þ90 5332416405
ncy Medicine Association of
e Association of Turkey. Production
ons.org/licenses/by-nc-nd/4.0/).solution containing trichlorfon tomoisture her skinwith the advice
of a veterinary the day before. She had ichthyoses and could not
beneﬁt from any other topical medicine to hydrate and soften her
skin. She was complaining about nausea, vomiting and fatigue. Her
vital signs were as follows: blood pressure, 140/80mmHg; pulse, 95
beats/min; respiratory rate, 40 breaths/min; and axillary temper-
ature, 36.7 C. She had salivation, myosis, tachypnea and increased
bowel sounds on admission. A total of 130 mg atropin bolus was
administered to dry secretions and 1200 mg pralidoxime (2-PAM)
was ordered. Her clothes were removed, her skin was gently rinsed
and washed. Supplemental oxygen was administered at a rate of
4 L/min. Cardiac and pulse oxymetric monitoring were also initi-
ated. Fluid replacement was initiated (3000 mL/m2/day). Her
plasma pseudocholinesterase level was remarkably low on admis-
sion. The laboratory ﬁndings including serum pseudocholines-
terase levels are listed in Table 1. Atropin infusion at a dose of
15 mg/day was started because recurrent atropin doses were
needed to resolve salivation. Tachypnea, respiratory depression and
fatigue became obvious with decreased pulse oximetric saturation.
Diarrhea was added as a cholinergic sign on the second day of
hospitalization. Endotracheal intubation, mechanical ventilatory
support and repeated atropin boluses were needed to manage se-
cretions. Atropine sulfate infusion rate was increased from 15 mg/
day to 100 mg/day after drying the secretions with a total dose of
50 mg given in a few minutes. Her hairs were shaved and plas-
mapheresis was performed on the 3rd day of hospitalization,and hosting by Elsevier B.V. on behalf of the Owner. This is an open access article
Table 1
Laboratory ﬁndings of the patient.
Parameter (normal range) On admission 4st day 7th day 10th day Follow-up visit 15th day
WBC (4.3e10.3 uL) 15,600 e e 8400 e
Hb (12e16 g/L) 12.1 e e 13.0 e
Hct (39.53e50.33%) 34.6 e e 38.2 e
Plt (156e373.3 uL) 277 e e 336 e
AST (5e40 U/L) 35 e 100 74 24
ALT (<41 U/L) 24 e 151 148 60
BUN (5e20 mg/dL) 10 7 9 14 7
Cr (0.8e1.2 mg/dL) 0.59 0.37 0.39 0.47 0.45
Na (135e145 mmol/L) 138 137 135 137 140
K (3.5e5.1 mmol/L) 4.0 3.9 4.0 4.3 4.5
PcHe (4.9e11.9 KU/L) 1.9 2.3 3.5 4.9 6.2
WBC: White blood cell, Hb: Hemoglobine, Hct: Hematocrite, Plt: Platelet, AST: Aspartate aminotransferase, ALT: Alanine aminotransferase, BUN: Blood urea nitrogen, Cr:
Creatinine, Na: Sodium, K: Potassium, PcHe: Pseudocholinesterase.
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on the second day. Plasmapheresis was performed in the ED by a
trained nurse from Therapeutic Apheresis Unit with an automatic
device (Fresenius-AS-TEC 204, Fresenius Hemocare, Redmon, WA).
Eight bags of fresh frozen plasma (1600 mL), a total of 500 mL of
human albumin 20% and 1500 mL 0.9% NaCl were used as
replacement.
Her cholinergic ﬁndings were resolved the next day and she was
extubated on the 4th day when atropin infusion was decreased to
60 mg/day. She was started total parenteral nutrition (TPN) on the
6th day. TPN was stopped because of elevation of hepatic enzymes
next day when her atropin infusion was decreased to 30 mg/day.
Atropin infusionwas tapered to zero in the next 2 days. She was fed
orally after 9th and dischargedwithout any sequela on the 10th day.
3. Discussion
Organophosphates cause serious human toxicity which depends
on the type, amount and concentration of the agent as well as the
route of exposure. The clinical effects may become apparent in
5 mine24 h after exposure. Time to onset of symptoms by inhala-
tion is the most rapid while by dermal exposure is the least.1 But
dermal integrity is a barrier, that means dermatitis or excoriations
may hasten the process.2 Cholinergic crisis is the sum of symptoms
of nicotinic and muscarinic effects of poisoning. The mnemonics
DUMBELLS, SLUDGE and the “Killer Bees” are all used to describe
the clinical manifestations (Defecation, Urination, Myosis, Muscle
Weakness, Bradycardia, Bronchorrhea, Bronchospasm, Emesis,
Lacrimation, Salivation and Gastrointestinal Pain). Unintentional
dermal exposure is not a rare way of poisoning by presenting
accidentally in sprayed or fogged areas in farms or houses. The
liposolubility and dermal absorption of these agents make them
potent and continuous toxic if dermal exposure is not realized or
sufﬁcient decontamination is not achieved.1
Decontamination is one of the major steps in the management
of intoxicated patients. Especially in dermal contamination,
removal of clothes, cleaning the skin bywiping out or washing with
soap and warmwater, shaving contaminated hairs are essential for
both patient andmedical staff to reduce ongoing absorption and re-
contamination. Skin integrity is also a barrier for chemical ab-
sorption.2,3 Absorption of poison can be easier and excessive for the
patients with dry, thickened and scaly skin like ichthyoses. It is a
dilemma to wash-wipe-shave such a patient or not because these
may let the poison permeate easier. As performed in our patient,
cleaning the skin may not be enough to reduce absorption, or even
may increase it.
Seek for other treatment modalities like blood transfusions,
hemodialysis, peritoneal dialysis, hemoperfusion for poisoning
cases took place in medical literature for the last 50 years. In themanagement of intoxicated patients, extracorporeal elimination
techniques are used and still being studied on since new beneﬁts
are being identiﬁed. Which method for extracorporeal elimination
is going to be preferred depends on water solubility, volume of
distribution, protein binding capacities, and elimination pathways
of toxic substances. Hemodialysis and hemoperfusion one by one or
in combination were used to eliminate OP compounds from blood.
There are many cases reporting the effectiveness of these
methods.4,5 Plasmapheresis (actually therapeutic plasma ex-
change) as another elimination process has been used to remove
immune complexes. Plasmapheresis has some advantages over
hemodialysis and hemoperfusion. First of all, patients do not have
to have central catheters because this procedure can be performed
via two large peripheral veins. Plasmapheresis, different from he-
modialysis and hemoperfusion, is independent from the size of
molecule to be cleared. Plasmapheresis is effective in elimination of
substances with high plasma protein binding capacity (>80%) and
low distribution volume (<0.2 L/kg bw).1,6,7 There are several re-
ports indicating effectiveness of plasmapheresis in different poi-
sonings like amitriptyline, phalloid mushroom, propranolol,
amlodipine, diltiazem, verapamil, carbamazepine, theophylline, L-
thyroxine, and heavy metals like mercury.7 It is the protein binding
capacity of those drugs/substances which make sense to use plas-
mapheresis for reducing plasma levels, and poisoning symptoms as
well. There are opposite opinions on the effectiveness of plasma-
pheresis in the management of OP poisoning. Nenov et al. reported
that they had tried to eliminate dimethoate (an OP) but they could
not detect any decrease in plasma concentrations of the toxic after
plasmapheresis.8 On the other hand, Guven et al reported clinical
improvement in patients with OP poisoning who were performed
plasmapheresis for sepsis.9,10 It may not be only the elimination of
OP but replacement of cholinesterase by fresh frozen plasma by
plasma exchange which helps in clinical improvement in patients
poisoned with OP. Plasmapheresis and therapeutic plasma ex-
change (TPE) are terms that identify different procedures but cause
confusion and are frequently misused.11 Plasmapheresis is the
procedure in which less than 15% of total plasma is removed and is
not replaced. TPE is another procedure in which separated plasma
is replaced with albumin and/or fresh frozen plasma and crystal-
loids. Similar as in other articles in the toxicology ﬁeld, we misuse
plasmapheresis since the procedure we performed was TPE to
eliminate toxic substances.
There are several reports supporting effectiveness of plasma-
pheresis in OP poisoning and intermediate syndrome.11e13 Our
patient had mild symptoms in the beginning but experienced
cholinergic crisis on the second day, when her skin was dried with
atropine. We conclude that her cracked and scaly skin has let an
easier penetration and absorption of OP. Despite aggressive atro-
pine and repeated oxime administration, she had confusion, was
N.R. Disel et al. / Turkish Journal of Emergency Medicine 16 (2016) 69e71 71hypoxic due to dysfunction of respiratory muscles and excessive
secretions. After plasmapheresis was performed, she became alert,
oxygen saturation was elevated, and plasma cholinesterase levels
were increased.
Plasmapheresis was performed in our patient once, and clinical
improvement was achieved. We suggest the widespread usage and
availability of plasmapheresis in toxicology clinics to manage
extraordinary and serious cases of OP intoxication, especially when
clinical worsening occurs despite atropine and oxime treatment.
Since this is an anecdotal case, further studies are needed to sup-
port use of plasmapheresis.Author contributions
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